124.43
price down icon1.72%   -2.18
after-market 시간 외 거래: 124.83 0.40 +0.32%
loading
전일 마감가:
$126.61
열려 있는:
$126.18
하루 거래량:
5.14M
Relative Volume:
0.89
시가총액:
$216.57B
수익:
$43.84B
순이익/손실:
$13.94B
주가수익비율:
15.56
EPS:
7.9979
순현금흐름:
$6.78B
1주 성능:
-2.75%
1개월 성능:
-6.52%
6개월 성능:
-4.65%
1년 성능:
+9.73%
1일 변동 폭
Value
$124.12
$126.55
1주일 범위
Value
$124.12
$128.77
52주 변동 폭
Value
$110.86
$140.84

애보트 래버러토리스 Stock (ABT) Company Profile

Name
명칭
Abbott Laboratories
Name
전화
(224) 667-6100
Name
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
직원
114,000
Name
트위터
@AbbottNews
Name
다음 수익 날짜
2025-10-15
Name
최신 SEC 제출 서류
Name
ABT's Discussions on Twitter

ABT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
ABT
Abbott Laboratories
124.43 220.36B 43.84B 13.94B 6.78B 7.9979
Medical Devices icon
BSX
Boston Scientific Corp
100.30 149.61B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
SYK
Stryker Corp
369.59 143.72B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
91.73 119.58B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
82.69 48.25B 5.69B 1.41B 577.90M 6.9828

애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-10 개시 The Benchmark Company Buy
2025-07-18 업그레이드 Jefferies Hold → Buy
2025-06-16 개시 Leerink Partners Market Perform
2024-10-08 개시 Oppenheimer Outperform
2024-09-19 개시 Piper Sandler Overweight
2024-07-30 다운그레이드 Edward Jones Buy → Hold
2024-05-30 개시 Goldman Buy
2023-07-21 업그레이드 Wolfe Research Underperform → Peer Perform
2023-05-30 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-04-20 재확인 Barclays Overweight
2023-04-20 재확인 Bernstein Outperform
2023-04-20 재확인 JP Morgan Overweight
2023-04-20 재확인 Raymond James Outperform
2023-04-20 재확인 UBS Buy
2023-04-20 재확인 Wolfe Research Underperform
2023-03-29 개시 UBS Buy
2022-10-26 개시 Mizuho Neutral
2022-10-18 개시 Barclays Overweight
2022-10-12 개시 Jefferies Hold
2022-07-06 개시 Wolfe Research Underperform
2022-03-02 재개 BofA Securities Buy
2022-01-27 재확인 Credit Suisse Outperform
2022-01-27 재확인 Morgan Stanley Overweight
2022-01-27 재확인 Raymond James Outperform
2022-01-27 재확인 UBS Buy
2021-12-10 개시 RBC Capital Mkts Outperform
2021-10-27 업그레이드 Atlantic Equities Neutral → Overweight
2021-10-14 개시 Redburn Neutral
2021-05-25 개시 Barclays Overweight
2021-04-15 개시 Atlantic Equities Neutral
2021-01-28 업그레이드 BTIG Research Neutral → Buy
2020-09-11 개시 Wolfe Research Outperform
2020-06-01 다운그레이드 Goldman Neutral → Sell
2020-03-05 개시 Citigroup Buy
2020-02-13 개시 Goldman Neutral
2020-02-06 재개 BTIG Research Neutral
2020-01-02 다운그레이드 Guggenheim Buy → Neutral
2019-06-13 재확인 BofA/Merrill Buy
2019-02-07 재확인 BofA/Merrill Buy
2019-01-02 다운그레이드 Citigroup Neutral → Sell
2018-11-30 업그레이드 Goldman Neutral → Buy
2018-10-16 개시 Barclays Overweight
2018-06-27 개시 Bernstein Outperform
2018-01-30 재확인 Citigroup Neutral
2018-01-25 재확인 Stifel Buy
2018-01-25 업그레이드 William Blair Mkt Perform → Outperform
2018-01-03 개시 Evercore ISI Outperform
2018-01-02 업그레이드 JP Morgan Neutral → Overweight
2018-01-02 업그레이드 Morgan Stanley Equal-Weight → Overweight
2017-10-19 재확인 RBC Capital Mkts Outperform
2017-10-19 재확인 Stifel Buy
모두보기

애보트 래버러토리스 주식(ABT)의 최신 뉴스

pulisher
04:40 AM

Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $162 - 富途牛牛

04:40 AM
pulisher
Oct 28, 2025

Abbott Laboratories (ABT): Evaluating Its Valuation Following Recent Share Price Pullback - simplywall.st

Oct 28, 2025
pulisher
Oct 28, 2025

How Abbott Laboratories stock reacts to inflationary pressuresWeekly Risk Report & AI Forecasted Stock Moves - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Data supports Abbott Tendyne mitral valve replacement - MassDevice

Oct 28, 2025
pulisher
Oct 28, 2025

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You? - The Motley Fool

Oct 28, 2025
pulisher
Oct 28, 2025

Is Abbott Laboratories stock a good choice for value investors2025 Geopolitical Influence & AI Forecasted Stock Moves - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Technical signs of recovery in Abbott LaboratoriesMarket Volume Summary & Target Return Focused Stock Picks - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

What makes Abbott Laboratories stock attractive to growth fundsM&A Rumor & Risk Adjusted Buy and Sell Alerts - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Will Abbott Laboratories (ABL) stock maintain strong growth2025 Market Overview & Community Consensus Stock Picks - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Abbott Laboratories, facing hundreds of lawsuits over safety of formula for premature babies, notches a win in federal court - Slipcase

Oct 27, 2025
pulisher
Oct 27, 2025

Abbott’s New Study on Dydrogesterone: A Potential Game-Changer for Endometriosis Pain - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Is Abbott Laboratories (Common Stock) (ABL0) stock a buy for dividend portfoliosJuly 2025 Price Swings & Precise Buy Zone Identification - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Abbott Laboratories wins Illinois court case on NEC baby formula claims - Global Food Industry News

Oct 27, 2025
pulisher
Oct 27, 2025

Using R and stats models for Abbott Laboratories forecastingWeekly Market Summary & Real-Time Volume Triggers - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What is the fair value estimate for Abbott Laboratories (ABL) stock in 2025Trade Risk Report & Smart Swing Trading Techniques - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will a bounce in Abbott Laboratories offer an exitSwing Trade & High Conviction Investment Ideas - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Is Abbott Laboratories stock a buy in volatile marketsGap Up & Verified Stock Trade Ideas - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum - MSN

Oct 26, 2025
pulisher
Oct 24, 2025

Abbott Laboratories wins lawsuit over safety of baby formula - Chicago Tribune

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Wins Third Bellwether as Judge Rules Human-Milk Alternative ‘Unfeasible’ - USA Herald

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Wins Third Bellwether In Cow Milk Baby Formula MDL - Law360

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott wins third of four 'bellwether' infant formula lawsuits - Crain's Chicago Business

Oct 24, 2025
pulisher
Oct 24, 2025

Protein Bar Market Size, Share, and Growth 2025-2035 | Abbott - openPR.com

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Can't Expand Glucose Monitor Sales Ban At UPC - Law360

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Laboratories (ABT): Exploring Valuation After a Recent Share Price Pullback - Yahoo Finance

Oct 24, 2025
pulisher
Oct 24, 2025

Meet RFK’s Corporate Underlings - The American Prospect

Oct 24, 2025
pulisher
Oct 23, 2025

Is Abbott Laboratories stock dividend growth reliableJuly 2025 Catalysts & Smart Swing Trading Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

How Abbott’s Innovative Partnerships Are Shaping Its 2025 Valuation Amid 12.8% YTD Gain - simplywall.st

Oct 23, 2025
pulisher
Oct 23, 2025

United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall - GlobeNewswire

Oct 23, 2025
pulisher
Oct 23, 2025

1 Safe-and-Steady Stock with Exciting Potential and 2 We Question - The Globe and Mail

Oct 23, 2025
pulisher
Oct 22, 2025

Synlait Milk Confirms Investment Regulator's Approval for Abbott's Acquisition of North Island Assets - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

A Look Into Abbott Laboratories Inc's Price Over Earnings - Sahm

Oct 22, 2025
pulisher
Oct 22, 2025

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

The 5 Most Interesting Analyst Questions From Abbott Laboratories’s Q3 Earnings Call - Yahoo Finance

Oct 22, 2025
pulisher
Oct 21, 2025

How Abbott Laboratories stock compares to growth peersMarket Movement Recap & Free Weekly Watchlist of Top Performers - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can Abbott Laboratories (Common Stock) (ABL0) stock sustain margin levelsGap Down & Entry and Exit Point Strategies - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Abbott Laboratories (ABL) stock cheap by valuation metricsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Abbott Laboratories showing signs of accumulationMarket Movement Recap & Expert Approved Momentum Ideas - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Volatility clustering patterns for Abbott LaboratoriesPortfolio Risk Report & Real-Time Market Trend Scan - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart to sell Abbott's CGM in US 1st - Fierce Biotech

Oct 21, 2025
pulisher
Oct 21, 2025

Abbott - Boston Athletic Association

Oct 21, 2025
pulisher
Oct 21, 2025

Daiwa Securities Adjusts Abbott Laboratories Price Target to $136 From $134, Maintains Outperform Rating - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart to be first US retailer to sell Abbott's continuous glucose monitor - Reuters

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart (WMT) Expands Health Offerings with Abbott's Lingo Gluco - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Functional Foods Forecast and Company Analysis Report 2025: A $678.32 Billion Market by 2033 Featuring Abbott, Amway, BASF, Cargill, Clif Ba, Danone, General Mills, Kellogg, Kerry, Nestle - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart said to become first physical retailer to sell Abbott’s OTC glucose monitor, Lingo - Seeking Alpha

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart to be first US retailer to sell Abbott's continuous glucose monitor, Axios reports - TradingView

Oct 21, 2025
pulisher
Oct 21, 2025

How to read the order book for Abbott Laboratories2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience - Insider Monkey

Oct 21, 2025
pulisher
Oct 21, 2025

Bringing Biomarkers to the Bedside: The Clinical Promise of Abbott’s TBI Test - NeurologyLive

Oct 21, 2025
pulisher
Oct 21, 2025

Did Mixed Segment Results and Narrowed Guidance Just Shift Abbott Laboratories' (ABT) Investment Narrative? - Yahoo Finance

Oct 21, 2025

애보트 래버러토리스 (ABT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_devices BSX
$100.30
price down icon 0.66%
medical_devices SYK
$369.59
price down icon 1.69%
medical_devices MDT
$91.73
price down icon 1.61%
medical_devices EW
$82.69
price up icon 0.61%
$77.38
price down icon 2.54%
자본화:     |  볼륨(24시간):